Title:
USE OF AN ADENOSINE A3 RECEPTOR AGONIST FOR INHIBITION OF VIRAL REPLICATION
Document Type and Number:
WIPO Patent Application WO2002055085
Kind Code:
A3
Abstract:
The present invention concerns the use of an active ingredient selected from the group consisting of agonists of the adenosine receptor system, for inhibiting viral replication in cells. In particular, the invention provides a composition and method for inhibiting viral replication in cells, the method comprising presenting to the cells an effective amount of the active ingredient. According to one embodiment, the adenosine agonist is an A3 receptor agonist (A3RAg). The invention is particularly useful, for although not limited to, inhibiting the replication of HIV virus in human cells.
Inventors:
FISHMAN PNINA (IL)
KHALILI KAMEL (US)
KHALILI KAMEL (US)
Application Number:
PCT/IL2002/000028
Publication Date:
December 19, 2002
Filing Date:
January 13, 2002
Export Citation:
Assignee:
CAN FITE BIOPHARMA LTD (IL)
FISHMAN PNINA (IL)
KHALILI KAMEL (US)
FISHMAN PNINA (IL)
KHALILI KAMEL (US)
International Classes:
A61K31/00; A61K31/52; A61K45/00; A61K31/522; A61K31/7076; A61P31/12; A61P31/18; (IPC1-7): A61K31/7076; A61P31/18
Domestic Patent References:
| WO1994021195A1 | 1994-09-29 | |||
| WO1999006053A1 | 1999-02-11 | |||
| WO1995002604A1 | 1995-01-26 | |||
| WO2001019360A2 | 2001-03-22 |
Foreign References:
| US5688774A | 1997-11-18 | |||
| US5773423A | 1998-06-30 | |||
| US6048865A | 2000-04-11 | |||
| US5573772A | 1996-11-12 |
Download PDF: